Autobio Diagnostics Co., Ltd. (SHA:603658)
33.89
-0.52 (-1.51%)
May 14, 2026, 3:00 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 19.37 billion as of May 14, 2026. Its market cap has decreased by -19.19% in one year.
Market Cap
19.37B
Enterprise Value
18.54B
Revenue
4.22B
Ranking
n/a
PE Ratio
18.73
Stock Price
33.89
Market Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 19.37B, an increase of 119.56%. That is a compound annual growth rate of 8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 19.37B | -4.32% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| APT Medical | 32.24B |
| Jiangsu Yuyue Medical Equipment & Supply | 29.52B |
| Lepu Medical Technology (Beijing) | 26.47B |
| MGI Tech | 20.87B |
| MeHow Innovative | 18.91B |
| Double Medical Technology | 16.76B |
| Jafron Biomedical | 15.40B |
| Shandong Weigao Blood Purification Products | 14.71B |